Altered Expression Patterns of Syndecan-1 and -2 Predict Biochemical Recurrence in Prostate Cancer

Asian Journal of Andrology - India
doi 10.1038/aja.2010.143
Full Text
Abstract

Available in full text

Categories
MedicineUrology
Date
Authors
Publisher

Medknow

Related search

Expression and Prognostic Role of Syndecan-2 in Prostate Cancer

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2009English

Signature of 24 Genes to Predict Prostate Cancer Recurrence

Science-Business eXchange
2014English

Determining Risk of Biochemical Recurrence in Prostate Cancer by Immunohistochemical Detection of PTEN Expression and Akt Activation

Clinical Cancer Research
Cancer ResearchOncology
2007English

Inhibition of Syndecan-1 Expression and Function in Oral Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
1994English

Androgen Receptor Regulation of the Seladin-1/Dhcr24 Gene: Altered Expression in Prostate Cancer

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2008English

High Levels of Phosphorylated Form of Akt-1 in Prostate Cancer and Non-Neoplastic Prostate Tissues Are Strong Predictors of Biochemical Recurrence

Clinical Cancer Research
Cancer ResearchOncology
2004English

Management of Biochemical Recurrence After Primary Localized Therapy for Prostate Cancer

Frontiers in Oncology
Cancer ResearchOncology
2012English

Reduced Connexin 43 Expression Is Associated With Tumor Malignant Behaviors and Biochemical Recurrence-Free Survival of Prostate Cancer

Oncotarget
Oncology
2016English

Immunohistochemical BCL-2 and Ki-67 Expression Predict Survival in Prostate Cancer Patients Followed Expectantly

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy